Retatrutide : Currently in Phase 3 trials, this triple agonist (GLP-1, GIP, and glucagon receptors) has shown 24.2% average weight loss in a Phase 2 study
Higher NAD enhances SIRT1 activity, promoting fat oxidation and mitochondrial remodeling via PGC-1 pathwaysmechanisms consistent with improved endurance and recovery potential (Cant et al., Cell Metabolism
443,444,445 Copper may positively affect iron transport, and systemic copper deficiency impedes iron transport and accumulation in tissues, ultimately leading to iron deficiency
J.AcharS.BulloughK
With regular use, experience noticeably smoother and softer skin
The 10 mg group had an adjusted hazard ratio of 0.58 (95% confidence interval: 0.350.95, P = 0.03), and the 25 mg group had an adjusted hazard ratio of 0.62 (95% confidence interval: 0.380.99, P = 0.046)